The randomized, multicenter DOMINOS study compared a regimen in which patients were given no oral steroids versus a regimen of standard oral steroids for at least three months, followed by steroid withdrawal where appropriate, in de novo low-risk kidney transplant patients receiving an induction by interleukin 2 receptor (IL-2R) inhibitor, cyclosporine (CsA), and early intensified enteric-coated mycophenolate sodium (EC-MPS) dosing to week 6 after transplant [9]. Here, IL2RA is linked to kidney transplant.